Monoclonal Antibodies to Dengue Fever E Protein

Applications
This invention presents serious of monoclonal mouse IgG and IgM antibodies against yellow fever virus and dengue fever, and the antibody-producing hybridoma cell lines. These antibodies have multiple applications in production of vaccine against yellow fever.

Advantages
These antibodies have been proved to be very helpful in testing, quality control, and manufacturing vaccines against yellow fever and dengue fever.  Antibodies available are for NS1 and E protein of dengue and yellow fever virus.

URV Reference Number: 6-1008C
Patent Information:
Category(s):
Research Tools
For Information, Contact:
Blaze Pharoah
Licensing Manager
University of Rochester
585-276-6600
blaze_pharoah@urmc.rochester.edu
Inventors:
Jacob Schlesinger
Keywords:
Antiviral
Therapy